Therapy Cells, Inc Receives USA Patent Granted for
Therapy Cells, Inc Receives USA Patent Granted for Revolutionary Cell Therapy
ACCESSWIRE via CMTX - Tue Aug 20, 9:56AM CDT
CHEYENNE, WY- (ACCESSWIRE - August 20,2013) - Therapy Cells Inc (OTC Pink: TCEL) announces that on 13 February 2013, US patent US 11/702,895 was awarded to renowned scientist Dr Patrick Casey and Transplantation Ltd, for his transformational cell therapy, exclusively licensed to Therapy Cells Inc for use in human applications.
This revolutionary science dispenses with the traditional notion that cells cannot divide once they are fully mature. Dr Casey has shown that adult cells, given the right environment, can in fact divide and be grown in the laboratory. These new cells can then be used for transportation back to damaged tissue in the body, to enact tissue and organ healing.
The research team headed by Dr Casey has to date treated more than 80 horses including thoroughbreds, standardbreds, polo ponies and horses at the highest level of equestrian competition.
"With a growing level of trial success in horses, Therapy Cells' target is to gain FDA approval, and in short order have human applications in human tendons," Dr Casey says. "An initial valuation of $30 million USD for our science and technology has been appraised. FDA approval for clinical use of this technology in humans, will likely increase this factor by at least 10 times." The horse is an FDA approved model species for athletic injuries.
Dr Casey is a Veterinary graduate from Massey University (BVSc, 1988), and graduate from the University of California in 1992 with a Doctor of Philosophy (PhD, Comparative Pathology). During his time in the United States he also completed an Equine Surgical Internship at Hagyard-Davidson and McGee, Lexington, Kentucky, followed by a three year residency programme in Equine Reproduction, with a minor in Equine Medicine at UC Davis. In 1992, 1993, and 1994 he received a post-doctoral fellowship from the Equine Research Laboratory at the University of California, which allowed him to set up with the late, world renowned, Professor Liggins at the University of Auckland, New Zealand.
Since 2011, Dr Casey has been chief scientific consultant to a public company in the USA - Therapy Cells Inc (TCEL on the OTC Market).
This exciting Bio Tech/Med tech Company holds the exclusive technology that allows adult cells from a specific tissue (e.g. Achilles tendon) to grow again from an individual to enact repair and regeneration of that tissue, effectively by-passing the need for Stem Cell treatment.
"The financial and curative potential of this biotechnology platform is immediately obvious," states Dr Casey. "When we talk about regenerative procedures, the ability to rejuvenate tissues and organs with cultivated natural cell therapy, it's easy to understand how enormous the opportunity and the impact will be. The awarding of this US Patent for our transformational science is a significant milestone in the steps we have been taking to get our therapies to market."
Contact:
Contact: Patrick Casey
Company Headquarters:
Address 1: 1712 Pioneer Ave., Ste 101
Address 2: Cheyenne
Phone: 001 877 861 0207
Email: therapycells@gmail.com
Website(s): http://www.therapycells.com/
SOURCE: Therapy Cells Inc.
http://www.accesswire.com/img.ashx?id=407021
XTRA Bitcoin Inc. (CBTC) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Collaboration to Captivate Art and Rock Enthusiasts When it comes to mixing rock and roll with fine art, Markus Klinko's exclusive photograph featuring the Hollywood Vampires hits the nail on the head. It’s not just an image; it’s a slice of modern rock history immortalized on paper. This new release, a portrait capturing the raw passion of Alice Cooper, Johnny...
Continue Reading
The Challenge of Moving AI to Production Diving headfirst into AI in finance? Well, Jacobi's bold move with their new toy, the Investment Management Harness, spotlights a filthy secret: the hurdles between a big idea and execution are seldom technological. We got AI shaving prototyping time down to just days, yet pushing to production? That's a marathon in itself. Boards...
Continue Reading
The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...
Continue Reading
Connecting IoT Insights: A Fresh Spin on Industry Collaboration Alright, stepping away from stocks and straight into tech talk—Cavli Wireless just dropped their shiny new industry mag, Cavli360, aiming to be a voice hub for all things IoT. This ain't just another glossy promo piece; it's a rallying cry to bring together the brains across the nets and fibers shaping our...
Continue Reading
Breaking Through Financial Barriers in Geothermal Energy Finally, we're seeing some real movement in the geothermal heat pump sector. The longtime hurdles that kept ground-sourced heating and cooling tech at arm's length from the everyday homeowner are starting to tumble, thanks to Enertech Global's latest initiatives. Enertech's Double Deal: A New Lease on Geothermal...
Continue Reading
Unpacking Sony's Latest Sensor: LYTIA 720 Tell me, when was the last time a tech drop made you shake your head in awe? Sony just pulled one of those moves with their latest toy, the LYTIA 720. We're talking a 50-effective megapixel CMOS image sensor crafted for mobile warriors, and it packs a punch that should have the competition looking over their shoulder. Dazzling...
Continue Reading
OppFi's Third Quarter Performance Unpacked OppFi's recent third-quarter disclosures should get investors pondering. They've launched a new line of credit product, plugging a gap in their service portfolio, and aimed to widen their customer net. Their targeted share repurchase of $6.7 million in stock isn't small potatoes either, showing a vote of confidence in their own...
Continue Reading
A Strategic Shift in Seasonal Hiring It ain't just about the holiday rush anymore, folks. Companies are waking up to the idea that seasonal gigs are more than a temporary Band-Aid. This year, nearly 2 out of 5 companies are planning to bring more seasonal folks into the fold compared to last year. That means a good dose of them are looking for longer-term value—like...
Continue Reading
A Streak That Speaks Volumes Did you catch the latest from Scottsdale? Montage Partners, that people-first private equity outfit, just notched its sixth straight year on Inc.'s Founder-Friendly Investors list. Not something you snag with a casual handshake or flimsy promises—this accolade is about real, boots-on-the-ground partnership. Apparently, 294 firms made the...
Continue Reading
Peeling Back the Layers of Stigma On World Psoriasis Day, we're flipping the script from pity parties to real change. IFPA's 'Look Beyond My Skin' campaign is rallying against the stigma choking young folks with psoriasis. You can't deny the massive size of this issue – over 100 million people wrangle with this condition globally. Yet, as many of these warriors are...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding the Growth of Cboe Global Markets Cboe Global Markets has displayed remarkable performance in the stock market over the past decade. Specifically, the company has outperformed the market by an average of 2.96% annually, resulting in a substantial annual return of approximately 14.72%. Presently, its market capitalization stands at around $26.52 billion,...
Continue Reading
Oilstainlab Unleashes the HF-11: A New Era in Automotive Innovation Oilstainlab, known for its playful and daring approach to car manufacturing, has once again transcended traditional automotive boundaries with their latest offering—the HF-11. This remarkable vehicle blends an alluring aesthetic with brain-numbing performance metrics that challenge what is possible....
Continue Reading
Nuwellis Inc Sees Significant Share Price Surge On a remarkable Wednesday, shares of Nuwellis Inc (NUWE) experienced an astonishing rise as the company disclosed that it has secured an essential patent for its cutting-edge blood filtering technology. The exciting news led to a 161.2% surge in its stock price, marking a significant moment for investors and the medical...
Continue Reading
ReCoat Revolution: A New Era for Floor Refinishing ReCoat Revolution has emerged as a game-changer in the floor refinishing industry by offering a faster, cleaner alternative to traditional methods. Founded by Ryan Steele, this innovative business is dedicated to revitalizing floors with minimal disruption. The recent opening of its new location marks a significant...
Continue Reading
Market Insights into Robotics System Integration The global robotics system integration market is poised for significant expansion, with expectations of growing by USD 4.95 billion from 2024 to 2028. This rapid development is fueled by innovations in artificial intelligence, which are redefining the landscape of automation. Research shows that the market is anticipated to...
Continue Reading